Westlake Chemical Partners LP Announces Fourth Quarter and Full Year 2020 Results
Westlake Chemical Partners LP (WLKP) reported a net income of $66.2 million for 2020, marking a $5.2 million increase from 2019. However, hurricanes Laura and Delta severely impacted operations, leading to force majeure declarations, which resulted in $41.3 million and $28.3 million in fixed margin payments in Q3 and Q4. Q4 net income dropped to $15.0 million from $17.4 million in 2019 due to lower sales volumes and increased maintenance costs. Despite challenges, WLKP maintained stable cash flows and announced a quarterly distribution of $0.4714 per unit, reflecting consistent returns to unitholders.
- Full year 2020 net income increased to $66.2 million, up from $61.0 million in 2019.
- Quarterly distribution of $0.4714 per unit announced, marking the 26th consecutive payment.
- MLP distributable cash flow coverage at 1.08x for Q4 2020 indicates strong cash flow management.
- Fourth quarter net income decreased by $2.4 million compared to Q4 2019 due to operational disruptions.
- Q4 cash flows from operating activities fell by $83.2 million year-over-year, impacting liquidity.
- Reduced MLP distributable cash flow of $15.6 million in Q4 2020, down from $18.8 million in Q4 2019.
Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership of
Net income attributable to the Partnership in the fourth quarter of 2020 of
Fourth quarter 2020 net income attributable to the Partnership of
Net income attributable to the Partnership of
"In spite of the unprecedented demand challenges that we faced in 2020 and the production outages resulting from the two hurricanes, the Partnership continued to deliver strong financial performance and distributions to unitholders. Our long-term Ethylene Sales Agreement with Westlake Chemical helps insulate us from ongoing market volatility and other events that could impact our operations. The nature of this agreement with our sponsor provides the ability to continue to deliver reliable earnings and cash flows, which enables us to deliver predictable and reliable distributions to our unitholders," said Albert Chao, President and Chief Executive Officer. "We are excited about the Partnership's future and continuing to deliver long-term value to our unitholders."
OpCo's Ethylene Sales Agreement with Westlake Chemical is designed to provide for stable and predictable cash flows. The agreement provides that
On January 25, 2021, the Partnership announced that the Board of Directors of Westlake Chemical Partners GP LLC had approved a quarterly distribution for the fourth quarter of 2020 of
The statements in this release and the related teleconference relating to matters that are not historical facts, such as those with respect to future distributions, earnings and cash flow, insulation from ongoing market volatility and delivery of long-term value to unitholders are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to, the COVID-19 pandemic and the response thereto; operating difficulties; the volume of ethylene that we are able to sell; the price at which we are able to sell ethylene; changes in the price and availability of feedstocks; changes in prevailing economic conditions; actions and commitments of Westlake Chemical Corporation; actions of third parties; inclement or hazardous weather conditions, including flooding, and the physical impacts of climate change; environmental hazards; changes in laws and regulations (or the interpretation thereof); inability to acquire or maintain necessary permits; inability to obtain necessary production equipment or replacement parts; technical difficulties or failures; labor disputes; difficulty collecting receivables; inability of our customers to take delivery; fires, explosions or other industrial accidents; our ability to borrow funds and access capital markets; and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to the Partnership's Annual Report on Form 10-K for the year ended December 31, 2019, which was filed with the SEC in February 2020, and Quarterly Report on Form 10-Q for the quarter ended September 30, 2020.
This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (
Use of Non-GAAP Financial Measures
This release makes reference to certain "non-GAAP" financial measures, such as MLP distributable cash flow and EBITDA. For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as a numerical measure of a registrant's historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") in the statement of income, balance sheet or statement of cash flows (or equivalent statements) of the registrant; or (2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. We report our financial results in accordance with U.S. GAAP, but believe that certain non-GAAP financial measures, such as MLP distributable cash flow and EBITDA, provide useful supplemental information to investors regarding the underlying business trends and performance of our ongoing operations and are useful for period-over-period comparisons of such operations. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with U.S. GAAP. We define MLP distributable cash flow as distributable cash flow less distributable cash flow attributable to Westlake's noncontrolling interest in OpCo and distributions attributable to the incentive distribution rights holder. MLP distributable cash flow does not reflect changes in working capital balances. We define EBITDA as net income before interest expense, income taxes, depreciation and amortization. MLP distributable cash flow and EBITDA are non-GAAP supplemental financial measures that management and external users of our consolidated financial statements, such as industry analysts, investors, lenders and rating agencies, may use to assess our operating performance as compared to other publicly traded partnerships, our ability to incur and service debt and fund capital expenditures and the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities. Reconciliations of MLP distributable cash flow to net income and to net cash provided by operating activities and of EBITDA to net income, income from operations and net cash provided by operating activities can be found in the financial schedules at the end of this press release.
Westlake Chemical Partners LP
Westlake Chemical Partners is a limited partnership formed by Westlake Chemical Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns a
Westlake Chemical Partners LP Conference Call Information:
A conference call to discuss Westlake Chemical Partners' fourth quarter 2020 results will be held Tuesday, February 23, 2021 at 12:00 PM Eastern Time (11:00 AM Central Time). To access the conference call, dial (855) 765-5686 or (234) 386-2848 for international callers, approximately 10 minutes prior to the scheduled start time and reference passcode 392 56 87.
A replay of the conference call will be available beginning two hours after its conclusion until 11:59 p.m. Eastern Time on Tuesday, March 2, 2021. To hear a replay, dial (855) 859-2056 or (404) 537-3406 for international callers. The replay passcode is 392 56 87.
The conference call will also be available via webcast at: https://edge.media-server.com/mmc/p/vsdxow8m and the earnings release can be obtained via the Partnership web page at: http://investors.wlkpartners.com/CorporateProfile.
WESTLAKE CHEMICAL PARTNERS LP ("WESTLAKE PARTNERS") CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
|
||||||||||||||||
|
|
Three Months Ended December 31, |
|
Twelve Months Ended December 31, |
||||||||||||
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
(In thousands of dollars, except per unit data) |
||||||||||||||
Revenue |
|
|
|
|
|
|
|
|
||||||||
Net sales—Westlake Chemical Corporation ("Westlake") |
|
$ |
228,223 |
|
|
$ |
233,860 |
|
|
$ |
888,245 |
|
|
$ |
937,625 |
|
Net co-product, ethylene and other sales—third parties |
|
17,429 |
|
|
38,938 |
|
|
78,425 |
|
|
154,246 |
|
||||
Total net sales |
|
245,652 |
|
|
272,798 |
|
|
966,670 |
|
|
1,091,871 |
|
||||
Cost of sales |
|
160,738 |
|
|
169,201 |
|
|
587,787 |
|
|
712,443 |
|
||||
Gross profit |
|
84,914 |
|
|
103,597 |
|
|
378,883 |
|
|
379,428 |
|
||||
Selling, general and administrative expenses |
|
7,305 |
|
|
7,844 |
|
|
25,895 |
|
|
29,278 |
|
||||
Income from operations |
|
77,609 |
|
|
95,753 |
|
|
352,988 |
|
|
350,150 |
|
||||
Other income (expense) |
|
|
|
|
|
|
|
|
||||||||
Interest expense—Westlake |
|
(2,337) |
|
|
(4,187) |
|
|
(12,038) |
|
|
(19,623) |
|
||||
Other income, net |
|
8 |
|
|
563 |
|
|
733 |
|
|
3,096 |
|
||||
Income before income taxes |
|
75,280 |
|
|
92,129 |
|
|
341,683 |
|
|
333,623 |
|
||||
Provision for income taxes |
|
156 |
|
|
219 |
|
|
564 |
|
|
728 |
|
||||
Net income |
|
75,124 |
|
|
91,910 |
|
|
341,119 |
|
|
332,895 |
|
||||
Less: Net income attributable to noncontrolling interests in Westlake Chemical OpCo LP ("OpCo") |
|
60,099 |
|
|
74,539 |
|
|
274,952 |
|
|
271,914 |
|
||||
Net income attributable to Westlake Partners |
|
$ |
15,025 |
|
|
$ |
17,371 |
|
|
$ |
66,167 |
|
|
$ |
60,981 |
|
|
|
|
|
|
|
|
|
|
||||||||
Net income per limited partner unit attributable to Westlake Partners (basic and diluted) |
|
|
|
|
|
|
|
|
||||||||
Common units |
|
$ |
0.43 |
|
|
$ |
0.49 |
|
|
$ |
1.88 |
|
|
$ |
1.77 |
|
|
|
|
|
|
|
|
|
|
||||||||
Distributions declared per unit |
|
$ |
0.4714 |
|
|
$ |
0.4714 |
|
|
$ |
1.8856 |
|
|
$ |
1.8391 |
|
|
|
|
|
|
|
|
|
|
||||||||
MLP distributable cash flow |
|
$ |
15,603 |
|
|
$ |
18,752 |
|
|
$ |
71,983 |
|
|
$ |
73,181 |
|
|
|
|
|
|
|
|
|
|
||||||||
Distribution declared |
|
|
|
|
|
|
|
|
||||||||
Limited partner units—public and privately held |
|
$ |
9,936 |
|
|
$ |
9,934 |
|
|
$ |
39,736 |
|
|
$ |
38,746 |
|
Limited partner units—Westlake |
|
6,657 |
|
|
6,657 |
|
|
26,629 |
|
|
25,972 |
|
||||
Total distribution declared |
|
$ |
16,593 |
|
|
$ |
16,591 |
|
|
$ |
66,365 |
|
|
$ |
64,718 |
|
EBITDA |
|
$ |
103,004 |
|
|
$ |
123,254 |
|
|
$ |
456,875 |
|
|
$ |
460,566 |
|
WESTLAKE CHEMICAL PARTNERS LP CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
|
||||||||
|
|
December 31,
|
|
December 31,
|
||||
|
|
|
|
|
||||
|
|
(In thousands of dollars) |
||||||
ASSETS |
|
|
|
|
||||
Current assets |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
17,154 |
|
|
$ |
19,923 |
|
Receivable under the Investment Management Agreement— Westlake Chemical Corporation ("Westlake") |
|
123,228 |
|
|
162,773 |
|
||
Accounts receivable, net—Westlake |
|
108,028 |
|
|
42,847 |
|
||
Accounts receivable, net—third parties |
|
11,029 |
|
|
9,914 |
|
||
Inventories |
|
3,474 |
|
|
2,484 |
|
||
Prepaid expenses and other current assets |
|
392 |
|
|
470 |
|
||
Total current assets |
|
263,305 |
|
|
238,411 |
|
||
Property, plant and equipment, net |
|
1,050,677 |
|
|
1,102,995 |
|
||
Other assets, net |
|
42,506 |
|
|
52,050 |
|
||
Total assets |
|
$ |
1,356,488 |
|
|
$ |
1,393,456 |
|
|
|
|
|
|
||||
LIABILITIES AND EQUITY |
|
|
|
|
||||
Current liabilities (accounts payable and accrued liabilities) |
|
$ |
39,754 |
|
|
$ |
38,849 |
|
Long-term debt payable to Westlake |
|
399,674 |
|
|
399,674 |
|
||
Other liabilities |
|
1,923 |
|
|
2,798 |
|
||
Total liabilities |
|
441,351 |
|
|
441,321 |
|
||
Common unitholders—public and privately held |
|
471,701 |
|
|
471,736 |
|
||
Common unitholder—Westlake |
|
48,270 |
|
|
48,350 |
|
||
General partner—Westlake |
|
(242,572) |
|
|
(242,572) |
|
||
Total Westlake Partners partners' capital |
|
277,399 |
|
|
277,514 |
|
||
Noncontrolling interest in OpCo |
|
637,738 |
|
|
674,621 |
|
||
Total equity |
|
915,137 |
|
|
952,135 |
|
||
Total liabilities and equity |
|
$ |
1,356,488 |
|
|
$ |
1,393,456 |
|
WESTLAKE CHEMICAL PARTNERS LP CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
|
||||||||
|
|
Twelve Months Ended December 31, |
||||||
|
|
2020 |
|
2019 |
||||
|
|
|
|
|
||||
|
|
(In thousands of dollars) |
||||||
Cash flows from operating activities |
|
|
|
|
||||
Net income |
|
$ |
341,119 |
|
|
$ |
332,895 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
||||
Depreciation and amortization |
|
103,154 |
|
|
107,320 |
|
||
Other balance sheet changes |
|
(70,876) |
|
|
10,592 |
|
||
Net cash provided by operating activities |
|
373,397 |
|
|
450,807 |
|
||
Cash flows from investing activities |
|
|
|
|
||||
Additions to property, plant and equipment |
|
(36,968) |
|
|
(43,707) |
|
||
Investments with Westlake under the Investment Management Agreement |
|
(349,000) |
|
|
(529,445) |
|
||
Maturities of investments with Westlake under the Investment Management Agreement |
|
388,000 |
|
|
515,445 |
|
||
Net cash provided by (used for) investing activities |
|
2,032 |
|
|
(57,707) |
|
||
Cash flows from financing activities |
|
|
|
|
||||
Net proceeds from common unit offering |
|
— |
|
|
62,661 |
|
||
Proceeds from debt payable to Westlake |
|
— |
|
|
123,511 |
|
||
Quarterly distributions to noncontrolling interest retained in OpCo by Westlake |
|
(311,835) |
|
|
(315,564) |
|
||
Quarterly distributions to unitholders |
|
(66,363) |
|
|
(62,084) |
|
||
Repayment of debt payable to Westlake |
|
— |
|
|
(201,445) |
|
||
Net cash used for financing activities |
|
(378,198) |
|
|
(392,921) |
|
||
Net increase (decrease) in cash and cash equivalents |
|
(2,769) |
|
|
179 |
|
||
Cash and cash equivalents at beginning of the year |
|
19,923 |
|
|
19,744 |
|
||
Cash and cash equivalents at end of the year |
|
$ |
17,154 |
|
|
$ |
19,923 |
|
WESTLAKE CHEMICAL PARTNERS LP RECONCILIATION OF MLP DISTRIBUTABLE CASH FLOW TO NET INCOME AND NET CASH PROVIDED BY OPERATING ACTIVITIES (Unaudited)
|
||||||||||||||||||||
|
|
Three Months
|
|
Three Months Ended December 31, |
|
Twelve Months Ended December 31, |
||||||||||||||
|
|
2020 |
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||||
|
|
(In thousands of dollars) |
||||||||||||||||||
Net cash provided by operating activities |
|
$ |
117,157 |
|
|
$ |
32,521 |
|
|
$ |
115,653 |
|
|
$ |
373,397 |
|
|
$ |
450,807 |
|
Changes in operating assets and liabilities and other |
|
(25,309) |
|
|
42,603 |
|
|
(23,743) |
|
|
(32,278) |
|
|
(117,912) |
|
|||||
Net Income |
|
91,848 |
|
|
75,124 |
|
|
91,910 |
|
|
341,119 |
|
|
332,895 |
|
|||||
Add: |
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation, amortization and disposition of property, plant and equipment |
|
26,476 |
|
|
25,387 |
|
|
27,048 |
|
|
104,154 |
|
|
107,835 |
|
|||||
Mark-to-market adjustment loss (gain) on derivative contracts |
|
1,572 |
|
|
(1,125) |
|
|
(5,695) |
|
|
(1,340) |
|
|
1,301 |
|
|||||
Less: |
|
|
|
|
|
|
|
|
|
|
||||||||||
Contribution to turnaround reserves |
|
(9,890) |
|
|
(10,240) |
|
|
(3,961) |
|
|
(39,937) |
|
|
(15,630) |
|
|||||
Maintenance capital expenditures |
|
(6,509) |
|
|
(11,485) |
|
|
(11,327) |
|
|
(37,343) |
|
|
(39,940) |
|
|||||
Distributable cash flow attributable to noncontrolling interest in OpCo |
|
(82,309) |
|
|
(62,058) |
|
|
(79,223) |
|
|
(294,670) |
|
|
(313,280) |
|
|||||
MLP distributable cash flow |
|
$ |
21,188 |
|
|
$ |
15,603 |
|
|
$ |
18,752 |
|
|
$ |
71,983 |
|
|
$ |
73,181 |
|
WESTLAKE CHEMICAL PARTNERS LP RECONCILIATION OF EBITDA TO NET INCOME AND NET CASH PROVIDED BY OPERATING ACTIVITIES (Unaudited)
|
||||||||||||||||||||
|
|
Three Months
|
|
Three Months Ended December 31, |
|
Twelve Months Ended December 31, |
||||||||||||||
|
|
2020 |
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||||
|
|
(In thousands of dollars) |
||||||||||||||||||
Net cash provided by operating activities |
|
$ |
117,157 |
|
|
$ |
32,521 |
|
|
$ |
115,653 |
|
|
$ |
373,397 |
|
|
$ |
450,807 |
|
Changes in operating assets and liabilities and other |
|
(25,309) |
|
|
42,603 |
|
|
(23,743) |
|
|
(32,278) |
|
|
(117,912) |
|
|||||
Net Income |
|
91,848 |
|
|
75,124 |
|
|
91,910 |
|
|
341,119 |
|
|
332,895 |
|
|||||
Less: |
|
|
|
|
|
|
|
|
|
|
||||||||||
Other income, net |
|
17 |
|
|
8 |
|
|
563 |
|
|
733 |
|
|
3,096 |
|
|||||
Interest expense |
|
(2,320) |
|
|
(2,337) |
|
|
(4,187) |
|
|
(12,038) |
|
|
(19,623) |
|
|||||
Income tax benefit (provision) |
|
15 |
|
|
(156) |
|
|
(219) |
|
|
(564) |
|
|
(728) |
|
|||||
Income from operations |
|
94,136 |
|
|
77,609 |
|
|
95,753 |
|
|
352,988 |
|
|
350,150 |
|
|||||
Add: |
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization |
|
25,923 |
|
|
25,387 |
|
|
26,938 |
|
|
103,154 |
|
|
107,320 |
|
|||||
Other income, net |
|
17 |
|
|
8 |
|
|
563 |
|
|
733 |
|
|
3,096 |
|
|||||
EBITDA |
|
$ |
120,076 |
|
|
$ |
103,004 |
|
|
$ |
123,254 |
|
|
$ |
456,875 |
|
|
$ |
460,566 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20210223005104/en/
FAQ
What was Westlake Chemical Partners' net income for 2020?
How did hurricanes impact Westlake Chemical Partners' financial performance?
What is the quarterly distribution announced for WLKP in February 2021?
How did MLP distributable cash flow change in Q4 2020 for WLKP?